Mr. Martin brings to the Chairman’s role over 25 years of experience in senior executive roles in the life sciences industry, with a focus on business development, operations, and financing.
MaxCyte, Inc., a global cell-based therapies and life sciences company, announced today that Amanda L. Murphy, CFA, has joined the Company as Chief Financial Officer (CFO). Ron Holtz, who has served as MaxCyte’s CFO since 2005, will become Senior Vice President and Chief Accounting Officer (SVP & CAO).
Dr. Sklavos joins Arcellx with over 15 years of experience in biomedical and clinical research in academic, government and industry settings. Dr. Sklavos brings broad drug development expertise to Arcellx as a result of managing multiple complex projects and portfolios comprised of various drug modalities including monoclonal and bispecific antibodies, antibody drug conjugates, peptide conjugates, and cell therapies.
MacroGenics Appoints Dr. Stephen Eck As Chief Medical Officer Rockville, MD, June 16, 2020 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based [….]
Novovax announced that Silvia Taylor, MBA, has joined the company as SVP, Investor Relations, and Corporate Affairs GAITHERSBURG, Md., June 17, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing [….]
Novavax Appoints Biotechnology Veteran David Mott to Board of Directors GAITHERSBURG, Md., June 16, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today [….]
Ulyana Desiderio joins the Maryland Department of Commerce as Director of BioHealth and Life Sciences Ulyana Desiderio joined the Department of Commerce in April 2020 as Director of BioHealth and Life [….]
Aurinia Appoints Joe Miller as Chief Financial Officer APRIL 27, 2020 VICTORIA, British Columbia & ROCKVILLE, Md.–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical [….]
Personal Genome Diagnostics Appoints Megan Bailey as Chief Executive Officer BALTIMORE, MD, (April 21, 2020) – Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, appointed Megan Bailey as [….]
Emergent BioSolutions Appoints Nina DeLorenzo as Senior Vice President of Global Public Affairs GAITHERSBURG, Md., April 06, 2020 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today announced the appointment of Nina DeLorenzo to the position [….]
